TrialHypertension (Dallas, Tex. : 1979)2011

Contrary effects of the receptor tyrosine kinase inhibitor vandetanib on constitutive and flow-stimulated nitric oxide elaboration in humans.

Erica L Mayer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.